A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants

NCT06116617 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombosis

Interventions

DRUG: SRSD107
DRUG: Placebo

Sponsor

Sirius Therapeutics Co., Ltd.